UMass Medical School

UMass Memorial Health on Monday announced the acquisition of the former Beaumont Rehabilitation and Skilled Nursing Center at 378 Plantation St. in Worcester, which cost $23.5 million, according to the Worcester County Registry of Deeds.

UMass Medical School in Worcester was among several groups to release on Tuesday a set of principles taking aim at racism in medical education and healthcare organizations.

In the wake of the coronavirus lockdowns and the changing news of the Delta variant, businesses are facing unprecedented obstacles as they try to bring their employees back to the office and retain a sense of normalcy. Work from home, remote, and hybrid options are just a few of the new models quickly revolutionizing workforces.

Q2i, a Boston-based digital health company, announced on Tuesday it has received approval to move to phase two of its Opioid Addiction Recovery Support – Contingency Management software application, a project done in partnership with UMass Medical School in Worcester and UConn School of Medicine.

The Cryo-EM Core facility at UMass Medical School received $2.8 million from the Massachusetts Life Sciences Center on Thursday to purchase a cryo-electron microscope to support the team’s structural biology research. 

Worcester Polytechnic Institute researcher Amity Manning has been awarded a $799,995 grant from the American Cancer Society to determine the role a critical tumor-suppressor protein plays in chromosome errors arising during cell division in cancer cells.

UMass Medical School in Worcester is participating in a study of antibodies treatments for COVID-19.

Early data in a trial, run in part at UMass Medical School in Worcester, for adolescents indicates the Moderna COVID-19 vaccine has a 95% efficacy with no serious safety concerns to date for individuals aged 12 to 17, as the pharmaceutical company works to receive approval for the vaccine’s widespread use in children.

Worcester’s UMass Medical School announced on Tuesday that Mireli Fino will be the next executive vice chancellor for MassBiologics on July 1, leading the organization dedicated to improving worldwide health.

A firm making gene therapy for rare diseases that was co-founded by a UMass Medical School professor has won regulatory approval to continue research and investigatory work for an ALS therapy.